Lu, Ying-Ying <br/><br/>
Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.  [electronic resource] 

 -  World journal of gastroenterology  Sep 2008 
 - 5403-11 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2219-2840 
<br/><br/><label>Standard No.: </label>10.3748/wjg.14.5403  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Apoptosis--drug effects<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neovascularization, Pathologic--drug therapy<br/>Pancreatic Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--therapeutic use<br/>Quinazolines--therapeutic use<br/>Transplantation, Heterologous<br/>Vascular Endothelial Growth Factor A--genetics